Evidence map›Paper›PMID 40741471›Full record

ArticleWorld journal of gastroenterology2025

Construction of a community-based primary screening and hospital-based confirmatory screening pathway in pediatric nonalcoholic fatty liver disease.

Ming-Jie Yao, Yun-Fei Xing, Shu-Hong Liu, Ya-Fei Peng, Shu-Han Yang, Juan-Juan Chen, Jing-Min Zhao, Hui Wang

Abstract read
In one paragraph

Article in World journal of gastroenterology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Ming-Jie YaoDepartment of Anatomy and Embryology, School of Basic Medical Sciences, Peking University Health Science Center, Beijing 100191, China.
Yun-Fei XingDepartment of Maternal and Child Health, School of Public Health, Peking University Health Science Center, Beijing 100191, China.
Shu-Hong LiuDepartment of Pathology and Hepatology, The Fifth Medical Center of PLA General Hospital, Beijing 100191, China.
Ya-Fei PengDepartment of Nursing, Nursing School of Dalian Medical University, Dalian 116044, Liaoning Province, China.
Shu-Han YangDepartment of Maternal and Child Health, School of Public Health, Peking University Health Science Center, Beijing 100191, China.
Juan-Juan ChenDepartment of Pharmacy, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450001, Henan Province, China.
Jing-Min ZhaoDepartment of Pathology, The Fifth Medical Center of Chinese PLA General Hospital, Beijing 100039, China.
Hui WangDepartment of Maternal and Child Health, School of Public Health, Peking University Health Science Center, Beijing 100191, China. huiwang@bjmu.edu.cn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundFibrosis is a critical event in the progression of pediatric nonalcoholic fatty liver disease (NAFLD).

aimTo develop less invasive models based on machine learning (ML) to predict significant fibrosis in Chinese NAFLD children.

methodsIn this cross-sectional study, 222 and 101 NAFLD children with available liver biopsy data were included in the development of screening models for tertiary hospitals and community health centers, respectively. Predictive factors were selected using least absolute shrinkage and selection operator regression and stepwise logistic regression analyses. Logistic regression (LR) and other ML models were applied to construct the prediction models.

resultsSimplified indicators of the ATS and BIU indices were constructed for tertiary hospitals and community health centers, respectively. When models based on the ATS and BIU parameter combinations were constructed, the random forest (RF) model demonstrated higher screening accuracy compared to the LR model (0.80 and 0.79 for the RF model and 0.72 and 0.77 for the LR model, respectively). Using cutoff values of 90% for sensitivity and 90% for specificity, the RF models could effectively identify and exclude NAFLD children with significant fibrosis in the internal validation set (with positive predictive values and negative prediction values exceeding 0.80), which could prevent liver biopsy in 60% and 71.4% of NAFLD children, respectively.

conclusionThis study developed new models for predicting significant fibrosis in NAFLD children in tertiary hospitals and community health centers, which can serve as preliminary screening tools to detect the risk population in a timely manner.

Indexed as

Liver CirrhosisMass ScreeningNon-alcoholic Fatty Liver DiseaseAdolescentBiopsyChildChinaCommunity Health CentersCross-Sectional StudiesDisease ProgressionFemaleHumansLiverMachine LearningMalePredictive Value of TestsChildrenLess invasive testMachine learningNonalcoholic fatty liver diseaseSignificant fibrosis

Identifiers

PMID40741471
PMCPMC12305124

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.